reslizumab

Ligand id: 8091

Name: reslizumab

Classification
Compound class Antibody
Approved drug? Yes (source: FDA (2016))
International Nonproprietary Names
INN number INN
8106 reslizumab
Synonyms
CDP-835
CDP835
Cinqair®
JES1-39D10
SCH55700
Database Links
Specialist databases
IMGT/mAb-DB 279
Other databases
Search PubMed clinical trials reslizumab
Search PubMed titles reslizumab
Search PubMed titles/abstracts reslizumab
Wikipedia Reslizumab
Comments
Reslizumab is a monoclonal antibody with antiinflammatory action. It is designed to treat eosinophil-driven inflammatory conditions of the airways, skin and gastrointestinal tract [1,4].